Vivos Method News Today

First Medicare-Accepted Oral Appliance Treatment for All Severities of Obstructive Sleep Apnea in Adults LITTLETON, Colo., April 9, 2024 - Vivos Therapeutics,...

Vivos' CARE oral devices for sleep apnea are now eligible for Medicare reimbursement, broadening treatment alternatives for beneficiaries.

Vivos reported positive business momentum following receiving FDA clearance for its oral appliances to treat severe OSA last November.

LITTLETON, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device...

Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 14,000 shares, a decrease of 84.0% from the December 31st total of 87,300 shares. Based on an average daily volume of 998,700 shares, […]

Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 46,400 shares, a decline of 26.1% from the April 30th total of 62,800 shares. Based on an average daily volume of 170,200 shares, the short-interest ratio […]

Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Profitability This table compares Vivos Therapeutics and […]

ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) and Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Profitability This table compares ReShape Lifesciences and […]

What a day it’s been for Vivos Therapeutics (NASDAQ:VVOS). The medical technology company saw its shares shoot over 800% higher on Wednesday after news...

With this unprecedented FDA clearance, Vivos redefines what it means to have a truly non-invasive treatment for all levels of OSA severity, opening new...